Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Novel phage display-derived H5N1-specific scFvs with potential use in rapid avian flu diagnosis.

Wu J, Zeng XQ, Zhang HB, Ni HZ, Pei L, Zou LR, Liang LJ, Zhang X, Lin JY, Ke CW.

J Microbiol Biotechnol. 2014 May;24(5):704-13.

2.

Isolation of recombinant phage antibodies targeting the hemagglutinin cleavage site of highly pathogenic avian influenza virus.

Dong J, Sakurai A, Nomura N, Park EY, Shibasaki F, Ueda H.

PLoS One. 2013;8(4):e61158. doi: 10.1371/journal.pone.0061158.

3.

Development of single-chain variable fragments (scFv) against influenza virus targeting hemagglutinin subunit 2 (HA2).

Li TW, Cheng SF, Tseng YT, Yang YC, Liu WC, Wang SC, Chou MJ, Lin YJ, Wang Y, Hsiao PW, Wu SC, Chang DK.

Arch Virol. 2016 Jan;161(1):19-31. doi: 10.1007/s00705-015-2625-6.

PMID:
26446888
4.

The antigenic architecture of the hemagglutinin of influenza H5N1 viruses.

Velkov T, Ong C, Baker MA, Kim H, Li J, Nation RL, Huang JX, Cooper MA, Rockman S.

Mol Immunol. 2013 Dec;56(4):705-19. doi: 10.1016/j.molimm.2013.07.010. Review.

PMID:
23933511
5.

Characterization of human single-chain antibodies against highly pathogenic avian influenza H5N1 viruses: mimotope and neutralizing activity.

Yang J, Yoshida R, Kariya Y, Zhang X, Hashiguchi S, Nakashima T, Suda Y, Takada A, Ito Y, Sugimura K.

J Biochem. 2010 Oct;148(4):507-15. doi: 10.1093/jb/mvq084.

PMID:
20675684
6.

A novel peptide ELISA for universal detection of antibodies to human H5N1 influenza viruses.

Velumani S, Ho HT, He F, Musthaq S, Prabakaran M, Kwang J.

PLoS One. 2011;6(6):e20737. doi: 10.1371/journal.pone.0020737.

7.

Altered specificity of single-chain antibody fragments bound to pandemic H1N1-2009 influenza virus after conversion of the phage-bound to the soluble form.

Kaku Y, Noguchi A, Okutani A, Inoue S, Tanabayashi K, Yamamoto Y, Hotta A, Suzuki M, Sugiura N, Yamada A.

BMC Res Notes. 2012 Sep 4;5:483. doi: 10.1186/1756-0500-5-483.

8.
9.

Genetic analysis of avian influenza A viruses isolated from domestic waterfowl in live-bird markets of Hanoi, Vietnam, preceding fatal H5N1 human infections in 2004.

Jadhao SJ, Nguyen DC, Uyeki TM, Shaw M, Maines T, Rowe T, Smith C, Huynh LP, Nghiem HK, Nguyen DH, Nguyen HK, Nguyen HH, Hoang LT, Nguyen T, Phuong LS, Klimov A, Tumpey TM, Cox NJ, Donis RO, Matsuoka Y, Katz JM.

Arch Virol. 2009;154(8):1249-61. doi: 10.1007/s00705-009-0429-2.

PMID:
19578928
10.

Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells.

Throsby M, van den Brink E, Jongeneelen M, Poon LL, Alard P, Cornelissen L, Bakker A, Cox F, van Deventer E, Guan Y, Cinatl J, ter Meulen J, Lasters I, Carsetti R, Peiris M, de Kruif J, Goudsmit J.

PLoS One. 2008;3(12):e3942. doi: 10.1371/journal.pone.0003942.

11.

Efficacy of single dose of a bivalent vaccine containing inactivated Newcastle disease virus and reassortant highly pathogenic avian influenza H5N1 virus against lethal HPAI and NDV infection in chickens.

Lee DH, Park JK, Kwon JH, Yuk SS, Erdene-Ochir TO, Jang YH, Seong BL, Lee JB, Park SY, Choi IS, Song CS.

PLoS One. 2013;8(3):e58186. doi: 10.1371/journal.pone.0058186.

12.

A novel pathogenic mechanism of highly pathogenic avian influenza H5N1 viruses involves hemagglutinin mediated resistance to serum innate inhibitors.

Panaampon J, Ngaosuwankul N, Suptawiwat O, Noisumdaeng P, Sangsiriwut K, Siridechadilok B, Lerdsamran H, Auewarakul P, Pooruk P, Puthavathana P.

PLoS One. 2012;7(5):e36318. doi: 10.1371/journal.pone.0036318.

13.

Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.

Shi H, Liu XF, Zhang X, Chen S, Sun L, Lu J.

Vaccine. 2007 Oct 16;25(42):7379-84.

PMID:
17870216
14.

Experimental challenge of chicken vaccinated with commercially available H5 vaccines reveals loss of protection to some highly pathogenic avian influenza H5N1 strains circulating in Hong Kong/China.

Connie Leung YH, Luk G, Sia SF, Wu YO, Ho CK, Chow KC, Tang SC, Guan Y, Malik Peiris JS.

Vaccine. 2013 Aug 2;31(35):3536-42. doi: 10.1016/j.vaccine.2013.05.076.

PMID:
23791547
15.

Receptor specificity and erythrocyte binding preferences of avian influenza viruses isolated from India.

Pawar SD, Parkhi SS, Koratkar SS, Mishra AC.

Virol J. 2012 Oct 30;9:251. doi: 10.1186/1743-422X-9-251.

16.

Fab MAbs specific to HA of influenza virus with H5N1 neutralizing activity selected from immunized chicken phage library.

Pitaksajjakul P, Lekcharoensuk P, Upragarin N, Barbas CF 3rd, Ibrahim MS, Ikuta K, Ramasoota P.

Biochem Biophys Res Commun. 2010 May 14;395(4):496-501. doi: 10.1016/j.bbrc.2010.04.040.

PMID:
20382115
17.

[Generation high yield vaccine strain wholly derived from avian influenza viruses by reverse genetics].

Liu M, Zhang Y, Liu CG, Pan WQ, Liu CN, Yang T.

Sheng Wu Gong Cheng Xue Bao. 2006 Sep;22(5):720-6. Chinese.

PMID:
17037192
18.

Free energy simulations reveal a double mutant avian H5N1 virus hemagglutinin with altered receptor binding specificity.

Das P, Li J, Royyuru AK, Zhou R.

J Comput Chem. 2009 Aug;30(11):1654-63. doi: 10.1002/jcc.21274.

PMID:
19399777
19.

[Preparation and identification of a single-chain antibody fragment against high pathogenic H5N1 avian influenza virus].

Fang Z, Luo WX, Wang MQ, Chen YW, Zhang J, Chen HL, Guan Y, Xia NS.

Sheng Wu Gong Cheng Xue Bao. 2007 Mar;23(2):292-6. Chinese.

PMID:
17460904
20.

Epitope mapping of neutralizing monoclonal antibody in avian influenza A H5N1 virus hemagglutinin.

Ohkura T, Kikuchi Y, Kono N, Itamura S, Komase K, Momose F, Morikawa Y.

Biochem Biophys Res Commun. 2012 Feb 3;418(1):38-43. doi: 10.1016/j.bbrc.2011.12.108.

PMID:
22226969
Items per page

Supplemental Content

Support Center